Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Who remembers BRE-EX?

<< Previous

Bullboard Posts

Next >>

Comment by SeeDonRunon Oct 07, 2021 11:30am

69 Views

Post# 33982229

RE:RE:RE:RE:Who remembers BRE-EX?

Well exactly. So why even bring up Bre Ex on this board when it has nothing in comparrison with Claritas?

If and when Claritas begins to get some great results then you can return and imply that it may be a scam like Bre Ex but until then best stick to your normal silly stuff.

losingmyshirt wrote: Results being tampered with"?

You can't tamper with nothing. They have no tests, therefore no results.

TO THE MOON pilgrims.(the long way)